One injection dropped LDL by 69 percent. Should we celebrate?
A new gene-editing therapy just dropped LDL cholesterol by 69 percent — with a single injection. One shot, permanent effect. Cue the headlines: “Game-changer!” “End of statins!” “Revolution in heart disease!”
Here we go again.
Let’s be clear: I’m not anti-innovation. I’m not against gene therapy. I’m against making the same mistake again and again, just with better marketing and shinier tools.
VERVE-102 is the latest miracle-in-a-vial — a CRISPR base-editing therapy that …
One injection dropped LDL by 69 percent. Should we celebrate?
















![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)






